October 31, 2024Open Access

Gelation embolism agents suppress clinical TACE-incited pro-metastatic microenvironment against hepatocellular carcinoma progression

Key Points

Key points are not available for this paper at this time.

Abstract

Excellent Young Science Fund for National Natural Science Foundation of China (82022033); National Natural Science Foundation of China (Grant No. 82373086, 82102761); Major scientific and technological innovation project of Wenzhou Science and Technology Bureau (Grant No. ZY2021009); Shanghai Young Top-Notch Talent.

Bookmark

View Full Paper

Cite This Study

Li et al. (Thu,) studied this question.

synapsesocial.com/papers/69dcc2aea5c75be4cfe53cab https://doi.org/https://doi.org/10.1016/j.ebiom.2024.105436

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Global burden of primary liver cancer in 2020 and predictions to 20402022 · 2,052 citations
2Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma2002 · 2,627 citations
3Conventional Transarterial Chemoembolization Versus Drug-Eluting Beads in Patients with Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis2021 · 48 citations
4Distribution and amino acid composition of protein groups located in different histological parts of maize grain1980 · 88 citations
5Hypoxia inducible factor HIF-1 promotes myeloid-derived suppressor cells accumulation through ENTPD2/CD39L1 in hepatocellular carcinoma2017 · 457 citations

Bookmark

View Full Paper